Effects of the Nitric Oxide Donor Nitroprusside on No-Reflow Phenomenon During Coronary Interventions for Acute Myocardial Infarction

We tested the effects of the nitric oxide donor nitroprusside as treatment for no reflow in 23 consecutive patients who underwent coronary angioplasty for acute myocardial infarction. No reflow was defined as a decrease of ≥1 Thrombolysis In Myocardial Infarction (TIMI) trial flow grade occurring af...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2005-06, Vol.95 (11), p.1358-1361
Main Authors: Pasceri, Vincenzo, Pristipino, Christian, Pelliccia, Francesco, Granatelli, Antonino, Speciale, Giulio, Roncella, Adriana, Pironi, Bruno, Capasso, Michele, Richichi, Giuseppe
Format: Article
Language:English
Subjects:
Angioplasty
Angioplasty, Balloon, Coronary
Biological and medical sciences
Cardiology. Vascular system
Coronary Circulation - drug effects
Coronary heart disease
Drug therapy
Female
Heart
Heart attacks
Humans
Male
Medical sciences
Middle Aged
Myocardial Infarction - physiopathology
Myocardial Infarction - therapy
Myocarditis. Cardiomyopathies
Nitric oxide
Nitric Oxide Donors - therapeutic use
Nitroprusside - therapeutic use
Prospective Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c420t-b41122572d43a70eb7fc8df3d8e91c0bed5f01de5df3c2e07815754a4c7e541b3
cites cdi_FETCH-LOGICAL-c420t-b41122572d43a70eb7fc8df3d8e91c0bed5f01de5df3c2e07815754a4c7e541b3
container_end_page 1361
container_issue 11
container_start_page 1358
container_title The American journal of cardiology
container_volume 95
creator Pasceri, Vincenzo
Pristipino, Christian
Pelliccia, Francesco
Granatelli, Antonino
Speciale, Giulio
Roncella, Adriana
Pironi, Bruno
Capasso, Michele
Richichi, Giuseppe
description We tested the effects of the nitric oxide donor nitroprusside as treatment for no reflow in 23 consecutive patients who underwent coronary angioplasty for acute myocardial infarction. No reflow was defined as a decrease of ≥1 Thrombolysis In Myocardial Infarction (TIMI) trial flow grade occurring after successful initial coronary recanalization. Nitroprusside induced a significant improvement in coronary flow, with an increase in TIMI flow grade from 1.5 ± 0.8 to 2.9 ± 0.3 (p
doi_str_mv 10.1016/j.amjcard.2005.01.082
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67844463</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S000291490500370X</els_id><sourcerecordid>847282721</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-b41122572d43a70eb7fc8df3d8e91c0bed5f01de5df3c2e07815754a4c7e541b3</originalsourceid><addsrcrecordid>eNqFkV9rFDEUxYModl39CEoQ9G3G3JnMvycp26qF2oroc8gkNzbDbLJNZqr9AH5vM-5AwRcfQsjhdw_n5hDyElgODOp3Qy73g5JB5wVjVc4gZ23xiGygbboMOigfkw1jrMg64N0JeRbjkJ4AVf2UnEDVMV7zckN-nxuDaorUGzrdIL2yU7CKXv-yGumZdz78lfwhzDEumnf0ymdf0Yz-J_1yg87v03H0bA7W_aA7H7yT4Z5euAnDHbrJehepST6nap6Qfr73S2orx4QYGdQCPCdPjBwjvljvLfn-4fzb7lN2ef3xYnd6mSlesCnrOUBRVE2heSkbhn1jVKtNqVvsQLEedWUYaKySpgpkTQtVU3HJVYMVh77ckrdH30PwtzPGSextVDiO0qGfo6iblnNelwl8_Q84-Dm4lE0UJStr4KxNUHWEVPAxBjTiEOw-LS-AiaUkMYi1JLGUJBiIVFKae7Waz_0e9cPU2koC3qyAjEqOJkinbHzg6pa3kGJuyfsjh-nP7iwGEZVFp1DbkEoV2tv_RPkD_u2z7w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230361408</pqid></control><display><type>article</type><title>Effects of the Nitric Oxide Donor Nitroprusside on No-Reflow Phenomenon During Coronary Interventions for Acute Myocardial Infarction</title><source>ScienceDirect Freedom Collection</source><creator>Pasceri, Vincenzo ; Pristipino, Christian ; Pelliccia, Francesco ; Granatelli, Antonino ; Speciale, Giulio ; Roncella, Adriana ; Pironi, Bruno ; Capasso, Michele ; Richichi, Giuseppe</creator><creatorcontrib>Pasceri, Vincenzo ; Pristipino, Christian ; Pelliccia, Francesco ; Granatelli, Antonino ; Speciale, Giulio ; Roncella, Adriana ; Pironi, Bruno ; Capasso, Michele ; Richichi, Giuseppe</creatorcontrib><description>We tested the effects of the nitric oxide donor nitroprusside as treatment for no reflow in 23 consecutive patients who underwent coronary angioplasty for acute myocardial infarction. No reflow was defined as a decrease of ≥1 Thrombolysis In Myocardial Infarction (TIMI) trial flow grade occurring after successful initial coronary recanalization. Nitroprusside induced a significant improvement in coronary flow, with an increase in TIMI flow grade from 1.5 ± 0.8 to 2.9 ± 0.3 (p &lt;0.0001) and in TIMI frame count from 46 ± 25 to 16 ± 5 (p &lt;0.0001). There were no significant adverse effects apart from transient hypotension. Intracoronary nitroprusside should be considered as a treatment of no reflow occurring in acute myocardial infarction.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2005.01.082</identifier><identifier>PMID: 15904643</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Angioplasty ; Angioplasty, Balloon, Coronary ; Biological and medical sciences ; Cardiology. Vascular system ; Coronary Circulation - drug effects ; Coronary heart disease ; Drug therapy ; Female ; Heart ; Heart attacks ; Humans ; Male ; Medical sciences ; Middle Aged ; Myocardial Infarction - physiopathology ; Myocardial Infarction - therapy ; Myocarditis. Cardiomyopathies ; Nitric oxide ; Nitric Oxide Donors - therapeutic use ; Nitroprusside - therapeutic use ; Prospective Studies</subject><ispartof>The American journal of cardiology, 2005-06, Vol.95 (11), p.1358-1361</ispartof><rights>2005 Excerpta Medica Inc.</rights><rights>2005 INIST-CNRS</rights><rights>Copyright Elsevier Sequoia S.A. Jun 1, 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-b41122572d43a70eb7fc8df3d8e91c0bed5f01de5df3c2e07815754a4c7e541b3</citedby><cites>FETCH-LOGICAL-c420t-b41122572d43a70eb7fc8df3d8e91c0bed5f01de5df3c2e07815754a4c7e541b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27898,27899</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16848146$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15904643$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pasceri, Vincenzo</creatorcontrib><creatorcontrib>Pristipino, Christian</creatorcontrib><creatorcontrib>Pelliccia, Francesco</creatorcontrib><creatorcontrib>Granatelli, Antonino</creatorcontrib><creatorcontrib>Speciale, Giulio</creatorcontrib><creatorcontrib>Roncella, Adriana</creatorcontrib><creatorcontrib>Pironi, Bruno</creatorcontrib><creatorcontrib>Capasso, Michele</creatorcontrib><creatorcontrib>Richichi, Giuseppe</creatorcontrib><title>Effects of the Nitric Oxide Donor Nitroprusside on No-Reflow Phenomenon During Coronary Interventions for Acute Myocardial Infarction</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>We tested the effects of the nitric oxide donor nitroprusside as treatment for no reflow in 23 consecutive patients who underwent coronary angioplasty for acute myocardial infarction. No reflow was defined as a decrease of ≥1 Thrombolysis In Myocardial Infarction (TIMI) trial flow grade occurring after successful initial coronary recanalization. Nitroprusside induced a significant improvement in coronary flow, with an increase in TIMI flow grade from 1.5 ± 0.8 to 2.9 ± 0.3 (p &lt;0.0001) and in TIMI frame count from 46 ± 25 to 16 ± 5 (p &lt;0.0001). There were no significant adverse effects apart from transient hypotension. Intracoronary nitroprusside should be considered as a treatment of no reflow occurring in acute myocardial infarction.</description><subject>Angioplasty</subject><subject>Angioplasty, Balloon, Coronary</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Coronary Circulation - drug effects</subject><subject>Coronary heart disease</subject><subject>Drug therapy</subject><subject>Female</subject><subject>Heart</subject><subject>Heart attacks</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - physiopathology</subject><subject>Myocardial Infarction - therapy</subject><subject>Myocarditis. Cardiomyopathies</subject><subject>Nitric oxide</subject><subject>Nitric Oxide Donors - therapeutic use</subject><subject>Nitroprusside - therapeutic use</subject><subject>Prospective Studies</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqFkV9rFDEUxYModl39CEoQ9G3G3JnMvycp26qF2oroc8gkNzbDbLJNZqr9AH5vM-5AwRcfQsjhdw_n5hDyElgODOp3Qy73g5JB5wVjVc4gZ23xiGygbboMOigfkw1jrMg64N0JeRbjkJ4AVf2UnEDVMV7zckN-nxuDaorUGzrdIL2yU7CKXv-yGumZdz78lfwhzDEumnf0ymdf0Yz-J_1yg87v03H0bA7W_aA7H7yT4Z5euAnDHbrJehepST6nap6Qfr73S2orx4QYGdQCPCdPjBwjvljvLfn-4fzb7lN2ef3xYnd6mSlesCnrOUBRVE2heSkbhn1jVKtNqVvsQLEedWUYaKySpgpkTQtVU3HJVYMVh77ckrdH30PwtzPGSextVDiO0qGfo6iblnNelwl8_Q84-Dm4lE0UJStr4KxNUHWEVPAxBjTiEOw-LS-AiaUkMYi1JLGUJBiIVFKae7Waz_0e9cPU2koC3qyAjEqOJkinbHzg6pa3kGJuyfsjh-nP7iwGEZVFp1DbkEoV2tv_RPkD_u2z7w</recordid><startdate>20050601</startdate><enddate>20050601</enddate><creator>Pasceri, Vincenzo</creator><creator>Pristipino, Christian</creator><creator>Pelliccia, Francesco</creator><creator>Granatelli, Antonino</creator><creator>Speciale, Giulio</creator><creator>Roncella, Adriana</creator><creator>Pironi, Bruno</creator><creator>Capasso, Michele</creator><creator>Richichi, Giuseppe</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20050601</creationdate><title>Effects of the Nitric Oxide Donor Nitroprusside on No-Reflow Phenomenon During Coronary Interventions for Acute Myocardial Infarction</title><author>Pasceri, Vincenzo ; Pristipino, Christian ; Pelliccia, Francesco ; Granatelli, Antonino ; Speciale, Giulio ; Roncella, Adriana ; Pironi, Bruno ; Capasso, Michele ; Richichi, Giuseppe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-b41122572d43a70eb7fc8df3d8e91c0bed5f01de5df3c2e07815754a4c7e541b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Angioplasty</topic><topic>Angioplasty, Balloon, Coronary</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Coronary Circulation - drug effects</topic><topic>Coronary heart disease</topic><topic>Drug therapy</topic><topic>Female</topic><topic>Heart</topic><topic>Heart attacks</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - physiopathology</topic><topic>Myocardial Infarction - therapy</topic><topic>Myocarditis. Cardiomyopathies</topic><topic>Nitric oxide</topic><topic>Nitric Oxide Donors - therapeutic use</topic><topic>Nitroprusside - therapeutic use</topic><topic>Prospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pasceri, Vincenzo</creatorcontrib><creatorcontrib>Pristipino, Christian</creatorcontrib><creatorcontrib>Pelliccia, Francesco</creatorcontrib><creatorcontrib>Granatelli, Antonino</creatorcontrib><creatorcontrib>Speciale, Giulio</creatorcontrib><creatorcontrib>Roncella, Adriana</creatorcontrib><creatorcontrib>Pironi, Bruno</creatorcontrib><creatorcontrib>Capasso, Michele</creatorcontrib><creatorcontrib>Richichi, Giuseppe</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pasceri, Vincenzo</au><au>Pristipino, Christian</au><au>Pelliccia, Francesco</au><au>Granatelli, Antonino</au><au>Speciale, Giulio</au><au>Roncella, Adriana</au><au>Pironi, Bruno</au><au>Capasso, Michele</au><au>Richichi, Giuseppe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of the Nitric Oxide Donor Nitroprusside on No-Reflow Phenomenon During Coronary Interventions for Acute Myocardial Infarction</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2005-06-01</date><risdate>2005</risdate><volume>95</volume><issue>11</issue><spage>1358</spage><epage>1361</epage><pages>1358-1361</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>We tested the effects of the nitric oxide donor nitroprusside as treatment for no reflow in 23 consecutive patients who underwent coronary angioplasty for acute myocardial infarction. No reflow was defined as a decrease of ≥1 Thrombolysis In Myocardial Infarction (TIMI) trial flow grade occurring after successful initial coronary recanalization. Nitroprusside induced a significant improvement in coronary flow, with an increase in TIMI flow grade from 1.5 ± 0.8 to 2.9 ± 0.3 (p &lt;0.0001) and in TIMI frame count from 46 ± 25 to 16 ± 5 (p &lt;0.0001). There were no significant adverse effects apart from transient hypotension. Intracoronary nitroprusside should be considered as a treatment of no reflow occurring in acute myocardial infarction.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>15904643</pmid><doi>10.1016/j.amjcard.2005.01.082</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 2005-06, Vol.95 (11), p.1358-1361
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_miscellaneous_67844463
source ScienceDirect Freedom Collection
subjects Angioplasty
Angioplasty, Balloon, Coronary
Biological and medical sciences
Cardiology. Vascular system
Coronary Circulation - drug effects
Coronary heart disease
Drug therapy
Female
Heart
Heart attacks
Humans
Male
Medical sciences
Middle Aged
Myocardial Infarction - physiopathology
Myocardial Infarction - therapy
Myocarditis. Cardiomyopathies
Nitric oxide
Nitric Oxide Donors - therapeutic use
Nitroprusside - therapeutic use
Prospective Studies
title Effects of the Nitric Oxide Donor Nitroprusside on No-Reflow Phenomenon During Coronary Interventions for Acute Myocardial Infarction
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-27T13%3A30%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20the%20Nitric%20Oxide%20Donor%20Nitroprusside%20on%20No-Reflow%20Phenomenon%20During%20Coronary%20Interventions%20for%20Acute%20Myocardial%20Infarction&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Pasceri,%20Vincenzo&rft.date=2005-06-01&rft.volume=95&rft.issue=11&rft.spage=1358&rft.epage=1361&rft.pages=1358-1361&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2005.01.082&rft_dat=%3Cproquest_cross%3E847282721%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c420t-b41122572d43a70eb7fc8df3d8e91c0bed5f01de5df3c2e07815754a4c7e541b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=230361408&rft_id=info:pmid/15904643&rfr_iscdi=true